Back

Effects of drug treatment on clinical outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Chronic heart failure (CHF) Pharmacologic therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Fiona Chan

University College London, London (United Kingdom of Great Britain & Northern Ireland)

31 More presentations in this session

Presentation thumbnail
Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling.
Doctor C. Santos-Gallego (New York, US)
Abstract
Presentation thumbnail
Iron status, respiratory muscle strength, and physical fitness in men with heart failure with reduced ejection fraction
Doctor M. Drozd (Wroclaw, PL)
Abstract
Presentation thumbnail
Glycer-AGEs is associated with the severity of cardiac function of diabetic cardiomyopathy(DbCM).
Assistant Professor H. Aoki (Uchinada, JP)
Abstract
Presentation thumbnail
Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/- heart failure in epirubicinum recipients for bladder cancer
Associate Professor A. Tase (Pitesti, RO)
Abstract Slides
Presentation thumbnail
Early, combined heart failure therapy attenuates doxorubicin cardiomyopathy in rats
Miss M. Lodi (Debrecen, HU)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources